Millennium Management’s Quince Therapeutics QNCX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $183K | Buy |
+110,682
| New | +$183K | ﹤0.01% | 3726 |
|
|
2024
Q3 | – | Sell |
-36,567
| Closed | -$27.4K | – | 4381 |
|
|
2024
Q2 | $27.4K | Sell |
36,567
-17,112
| -32% | -$12.8K | ﹤0.01% | 3828 |
|
|
2024
Q1 | $56.9K | Sell |
53,679
-5,768
| -10% | -$6.11K | ﹤0.01% | 3885 |
|
|
2023
Q4 | $62.4K | Sell |
59,447
-481
| -0.8% | -$505 | ﹤0.01% | 3766 |
|
|
2023
Q3 | $67.1K | Sell |
59,928
-1,479
| -2% | -$1.66K | ﹤0.01% | 3846 |
|
|
2023
Q2 | $92.4K | Sell |
61,407
-186,606
| -75% | -$281K | ﹤0.01% | 3878 |
|
|
2023
Q1 | $387K | Sell |
248,013
-347,788
| -58% | -$543K | ﹤0.01% | 3542 |
|
|
2022
Q4 | $380K | Buy |
595,801
+137,810
| +30% | +$87.9K | ﹤0.01% | 3778 |
|
|
2022
Q3 | $609K | Buy |
457,991
+112,582
| +33% | +$150K | ﹤0.01% | 3698 |
|
|
2022
Q2 | $767K | Buy |
345,409
+279,239
| +422% | +$620K | ﹤0.01% | 3616 |
|
|
2022
Q1 | $410K | Sell |
66,170
-500,511
| -88% | -$3.1M | ﹤0.01% | 4204 |
|
|
2021
Q4 | $7.15M | Buy |
566,681
+562,108
| +12,292% | +$7.09M | ﹤0.01% | 1912 |
|
|
2021
Q3 | $419K | Buy |
+4,573
| New | +$419K | ﹤0.01% | 4294 |
|
|
2021
Q2 | – | Sell |
-6,645
| Closed | -$239K | – | 5290 |
|
|
2021
Q1 | $239K | Sell |
6,645
-97,445
| -94% | -$3.5M | ﹤0.01% | 4072 |
|
|
2020
Q4 | $2.89M | Buy |
+104,090
| New | +$2.89M | ﹤0.01% | 2264 |
|
|
2020
Q3 | – | Sell |
-25,181
| Closed | -$1.17M | – | 3835 |
|
|
2020
Q2 | $1.17M | Sell |
25,181
-510
| -2% | -$23.6K | ﹤0.01% | 2321 |
|
|
2020
Q1 | $1.17M | Buy |
+25,691
| New | +$1.17M | ﹤0.01% | 1906 |
|
|
2019
Q4 | – | Sell |
-21,239
| Closed | -$529K | – | 3735 |
|
|
2019
Q3 | $529K | Buy |
21,239
+8,747
| +70% | +$218K | ﹤0.01% | 2660 |
|
|
2019
Q2 | $531K | Buy |
+12,492
| New | +$531K | ﹤0.01% | 2710 |
|